12 HR acetazolamide 500 MG Extended Release Oral Capsule — RxCUI 562524
RxNorm drug concept · Semantic clinical drug
RxCUI 562524
Semantic clinical drug · SCD
● Current RxNorm concept 15 FDA products
29 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI562524
Official name12 HR acetazolamide 500 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asacetaZOLAMIDE 500 MG 12HR Extended Release Oral Capsule
FDA products mapped15
Package NDCs mapped29
Reported Medicaid activity (SDUD)49,820 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetazolamide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is used as an add-on treatment, most commonly for glaucoma. Depending on the product, it is also used for swelling from heart failure, certain seizure disorders, and preventing...
- Tablets and capsules are taken by mouth, and the injection is given in a vein by a professional. Extended-release capsules for glaucoma are usually taken morning and evening. For m...
- Tingling in fingers or face, more urination, tiredness, nausea, appetite or taste changes, and drowsiness are among the reported effects. Mention them if they bother you.
- Call right away if you get a rash, blisters, fever, sore throat, unusual bruising, yellow skin or eyes, confusion, or swelling of the face. Acetazolamide is a sulfa-type drug, and...
🕸️ Concept Web — How 12 HR acetazolamide 500 MG Extended Release Oral... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
12 HR acetazolamide 500 MG Extended Release Oral Capsule
RxCUI 562524 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Acetazolamide
167IN
-
Acetazolamide
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetazolamide Extended Release Oral Capsule
370526SCDF -
Acetazolamide Oral Product
1152847SCDG -
Acetazolamide Pill
1152848SCDG -
Extended Release Oral Capsule
316943DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Acetazolamide Extended Release Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetazolamide 500 MG
317288SCDC
-
Acetazolamide 500 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acetazolamide 500 MG
SCDC · 317288 -
Acetazolamide Extended Release Oral Capsule
SCDF · 370526 -
Acetazolamide Oral Product
SCDG · 1152847 -
Acetazolamide Pill
SCDG · 1152848
📦 FDA Products & Package NDCs
15 products · 29 package NDCs
29 package NDCs map to RxCUI 562524 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 16729-0331-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16729-331-01) | acetazolamide | Accord Healthcare Inc. | 2021-11-19 |
| 23155-0787-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (23155-787-01) | Acetazolamide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2021-02-15 |
| 42571-0243-01 | 100 CAPSULE in 1 BOTTLE (42571-243-01) | ACETAZOLAMIDE EXTENDED-RELEASE | Micro Labs Limited | 2020-12-01 |
| 46708-0349-31 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46708-349-31) | Acetazolamide | Alembic Pharmaceuticals Limited | 2019-02-20 |
| 46708-0349-91 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46708-349-91) | Acetazolamide | Alembic Pharmaceuticals Limited | 2019-02-20 |
| 50090-5945-00 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50090-5945-0) | Acetazolamide | A-S Medication Solutions | 2022-03-23 |
| 50268-0042-12 | 20 BLISTER PACK in 1 BOX (50268-042-12) / 1 CAPSULE in 1 BL... | ACETAZOLAMIDE EXTENDED-RELEASE | AvPAK | 2022-07-20 |
| 50742-0233-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50742-233-01) | Acetazolamide | Ingenus Pharmaceuticals, LLC | 2017-07-31 |
| 60687-0578-21 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-578-21) / 1 CAPS... | acetazolamide | American Health Packaging | 2020-10-27 |
| 62135-0612-60 | 60 CAPSULE, EXTENDED RELEASE in 1 PACKAGE (62135-612-60) | Acetazolamide | Chartwell RX, LLC | 2023-05-09 |
| 62332-0349-31 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-349-31) | Acetazolamide | Alembic Pharmaceuticals Inc. | 2019-02-20 |
| 62332-0349-91 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-349-91) | Acetazolamide | Alembic Pharmaceuticals Inc. | 2019-02-20 |
| 65841-0762-01 | 100 CAPSULE in 1 BOTTLE (65841-762-01) | acetazolamide | Zydus Lifesciences Limited | 2019-04-10 |
| 65841-0762-05 | 500 CAPSULE in 1 BOTTLE (65841-762-05) | acetazolamide | Zydus Lifesciences Limited | 2019-04-10 |
| 65841-0762-06 | 30 CAPSULE in 1 BOTTLE (65841-762-06) | acetazolamide | Zydus Lifesciences Limited | 2019-04-10 |
| 65841-0762-10 | 1000 CAPSULE in 1 BOTTLE (65841-762-10) | acetazolamide | Zydus Lifesciences Limited | 2019-04-10 |
| 65841-0762-16 | 90 CAPSULE in 1 BOTTLE (65841-762-16) | acetazolamide | Zydus Lifesciences Limited | 2019-04-10 |
| 65841-0762-30 | 10 BLISTER PACK in 1 CARTON (65841-762-30) / 10 CAPSULE in... | acetazolamide | Zydus Lifesciences Limited | 2019-04-10 |
| 69367-0209-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69367-209-01) | Acetazolamide | Westminster Pharmaceuticals, LLC | 2023-04-20 |
| 70518-4646-00 | 50 POUCH in 1 BOX (70518-4646-0) / 1 CAPSULE, EXTENDED RELE... | Acetazolamide | REMEDYREPACK INC. | 2026-04-28 |
| 70710-1591-00 | 1000 CAPSULE in 1 BOTTLE (70710-1591-0) | acetazolamide | Zydus Pharmaceuticals (USA) Inc. | 2019-05-08 |
| 70710-1591-01 | 100 CAPSULE in 1 BOTTLE (70710-1591-1) | acetazolamide | Zydus Pharmaceuticals (USA) Inc. | 2019-05-08 |
| 70710-1591-03 | 30 CAPSULE in 1 BOTTLE (70710-1591-3) | acetazolamide | Zydus Pharmaceuticals (USA) Inc. | 2019-05-08 |
| 70710-1591-04 | 10 BLISTER PACK in 1 CARTON (70710-1591-4) / 10 CAPSULE in... | acetazolamide | Zydus Pharmaceuticals (USA) Inc. | 2019-05-08 |
| 70710-1591-05 | 500 CAPSULE in 1 BOTTLE (70710-1591-5) | acetazolamide | Zydus Pharmaceuticals (USA) Inc. | 2019-05-08 |
| 70710-1591-09 | 90 CAPSULE in 1 BOTTLE (70710-1591-9) | acetazolamide | Zydus Pharmaceuticals (USA) Inc. | 2019-05-08 |
| 71335-9729-01 | 180 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-9729-1) | acetazolamide | Bryant Ranch Prepack | 2026-04-09 |
| 71335-9729-02 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-9729-2) | acetazolamide | Bryant Ranch Prepack | 2023-06-09 |
| 71335-9729-03 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-9729-3) | acetazolamide | Bryant Ranch Prepack | 2026-04-09 |
Observed labelers:
Zydus Lifesciences Limited (6) ·
Zydus Pharmaceuticals (USA) Inc. (6) ·
Bryant Ranch Prepack (3) ·
Alembic Pharmaceuticals Inc. (2) ·
Alembic Pharmaceuticals Limited (2) ·
A-S Medication Solutions (1)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.